Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Abstract Background The risk of thromboembolic events is higher among cancer patients, especially in patients undergoing chemotherapy. Cisplatin-based regimens claim to be associated with a very high thromboembolic rate. In this study, we report on our own experience with thrombosis among patients o...

Full description

Bibliographic Details
Main Authors: Hikmat Abdel-Razeq, Asem Mansour, Hazem Abdulelah, Anas Al-Shwayat, Mohammad Makoseh, Mohammad Ibrahim, Mahmoud Abunasser, Dalia Rimawi, Abeer Al-Rabaiah, Rozan Alfar, Alaa’ Abufara, Alaa Ibrahim, Anas Bawaliz, Yousef Ismael
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Thrombosis Journal
Subjects:
Cisplatin
Chemotherapy
Thrombosis
Cancer
Online Access:http://link.springer.com/article/10.1186/s12959-018-0161-9

Internet

http://link.springer.com/article/10.1186/s12959-018-0161-9

Similar Items